Laurus Synthesis

Hyderabad, Telangana, India
Small Molecule API Intermediates High-Potency APIs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Laurus Synthesis

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Hyderabad, Telangana, India
Website
Modalities
Small Molecule API, Intermediates, High-Potency APIs
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Laurus Synthesis

Laurus Synthesis is a contract development and manufacturing organization (CDMO). Capabilities: Small Molecule API, Intermediates, High-Potency APIs. 1 manufacturing site registered with the U.S. FDA. Website: https://www.lauruslabs.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Laurus Synthesis FDA Inspection History

2023-12
NAI VAI OAI
Date Site Type Observations Classification
2023-12-12
Laurus Synthesis Private Limited
Visakhapatnam Company-level
Drug Quality Assurance No Official Action Indicated (OAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Laurus Synthesis

How many FDA inspections does Laurus Synthesis have on record?
CDMO Signal tracks 1 FDA inspection for Laurus Synthesis, sourced from the FDA inspection database. See the full inspection history above.
Has Laurus Synthesis received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Laurus Synthesis.
Does Laurus Synthesis have a CDMO Signal Score?
Not yet. Laurus Synthesis is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Laurus Synthesis for a manufacturing program?
Use the free AI matchmaker to compare Laurus Synthesis against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Aurore Life Sciences
Hyderabad, Telangana, India
Small Molecule API, Intermediates, High-Potency APIs, Controlled Substances
Axplora
Paris, France
Small Molecule API, Intermediates, High-Potency APIs, Custom Synthesis
Archimica
Lodi, Italy
Small Molecule API, Intermediates, High-Potency APIs
ChemExpress
Shanghai, China
Small Molecule API, Intermediates, High-Potency APIs, ADC / Bioconjugation, Peptides, Oligonucleotide
Kolon Life Science
Gwacheon, South Korea
Small Molecule API, Intermediates, Oligonucleotide, High-Potency APIs

Compare Laurus Synthesis with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Laurus Synthesis
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.